-
+18 +3
Thousands taking antidepressants for pain despite insufficient evidence they work, say experts
Hundreds of thousands of Britons are taking antidepressants for chronic pain without enough evidence they work, according to a large study. Researchers looked at drugs commonly prescribed by the NHS including amitriptyline, duloxetine, fluoxetine (Prozac), citalopram, paroxetine (Seroxat) and sertraline.
-
+18 +2
Reversing dementia with diet- a 2021 update - Dr Paul Mason
-
+31 +4
Seres to start selling 'poop pill' in June at $17,500 per course
Price gouging much?
-
+23 +4
Legal use of medicinal cannabis on the rise
New research from the University of Sydney's Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically.
-
+23 +6
India: Doctor plans womb transplant for trans woman to carry children
A doctor in India is planning to transplant a womb into a transgender woman, possibly enabling her to carry children, a report says. New Delhi-based surgeon Dr Narendra Kaushik plans to perform the surgery at his clinic using a donated organ from a living or dead donor, according to The Mirror. "Every transgender woman wants to be as female as possible," Kaushik told the paper.
-
+2 +1
CRISPR-edited fat shrank tumors in mice. Someday, it could work in people, scientists say.
Fat sucked out of the body and tweaked with the gene-editing tool CRISPR could be used to treat cancer, a study of mice and transplanted human tissues hints. However, it remains to be seen whether the experimental therapy would be safe and effective in people.
-
+17 +1
An experimental cancer trial in France is getting a boost from the Gates Foundation: ‘Potential game-changer’
The Bill & Melinda Gates Foundation is known for spending billions to fight infectious diseases in developing countries, so a new investment in a French biotech company feels somewhat unusual. Smart Immune will receive $5 million from the foundation, according to the Financial Times. The company has developed a thymus-empowered T-cell therapy platform, called ProTcell, “to fully and rapidly re-arm the immune system.”
-
+4 +1
Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030
Moderna's chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new vaccines.
-
+20 +1
'Life-changing' cancer drug that can help patients live longer approved for NHS use
Olaparib targets cancers with BRCA 1 or BRCA 2 mutations, stopping cancer cells from being able to repair their DNA, which in turn causes the cancerous cells to die.
-
+17 +6
First-of-its-kind mRNA treatment could wipe out a peanut allergy
Peanut and tree nut allergies affect around three million Americans, yet there’s only one approved treatment and it only tackles its severity. And despite the amount of research behind finding a way to counter, or cure, this often deadly condition, there's been only glimmers of hope for sufferers.
-
+21 +2
New drug offers “two-for-one” treatment of heart failure, sleep apnea
Heart failure is a global health problem commonly complicated by sleep apnea, a co-morbidity that further reduces a person’s lifespan. A promising new drug has been developed that could treat heart failure and sleep apnea by targeting the nervous activity that drives both.
-
+14 +4
'The post-antibiotic era': WHO warns of too few new drugs for deadly superbugs
Late last year, one of Dr. Vance Fowler’s patients — a man in his 60s who’d returned to North Carolina from visiting his family in Nepal — died of a bacterial infection. He’d been treated at a top U.S. hospital with access to the strongest antibiotics. But the infection, a drug-resistant strain of E. coli, surged on.
-
+9 +2
Stroke survivor moves hand for first time in nine years after spinal stimulation
A stroke survivor partially paralysed on her left side has been able to move her hand and arm for the first time in nine years following spinal cord stimulation. Heather Rendulic, who had a stroke in 2012 when she was 22, was left with no mobility in her left hand as a result of chronic post-stroke muscle weakness. Researchers from the University of Pittsburgh and Carnegie Mellon University in the US used their new technology to stimulate Rendulic’s spinal cord in the neck area.
-
+12 +3
German Man with HIV Becomes Third Patient to be Cleared of Virus with Stem-Cell Therapy
A 53-year-old man in Germany, referred to as the "Düsseldorf patient," has become at least the third person to be declared cured of HIV. The man underwent a bone marrow transplant in 2013, replacing his bone marrow cells with HIV-resistant stem cells from a donor who carried the genetic mutation CCR5Δ32/Δ32, which prevents the CCR5 protein from being expressed on the cell surface.
-
+22 +2
New 'biohybrid' implant will restore function in paralyzed limbs
Researchers from the University of Cambridge have created a new type of neural implant that could restore limb function in paralyzed limbs. The developed device works in sync between the brain and paralyzed limbs - it combines flexible electronics and human stem cells to "better integrate" with the nerve and drive limb function, according to a press release.
-
+15 +3
Saving babies with a US$1 smart glove
A low-cost “smart glove” designed to sense the position of a baby during labour could prove a life-saving intervention in places with limited resources, say the UK-based developers.
-
+14 +3
Gynecology was built on Black women's suffering. We're still reckoning with its racist roots today
Modern gynecology was borne of experimentation of enslaved Black women, historian Dr. Deirdre Cooper Owens explains
-
+24 +4
Is Saliva the Next Frontier in Cancer Detection?
In the late 1950s, dentist and U.S. Navy Captain Kirk C. Hoerman, then a young man in his 30s, attempted to answer a bold question: Might the saliva of prostate cancer patients have different characteristics from that of healthy people? Could it contain traces of a disease that’s so far away from the mouth?
-
+17 +3
Statin therapy is not warranted for a person with high... : Current Opinion in Endocrinology, Diabetes and Obesity
lipoprotein cholesterol (LDL-C). We have assessed the value of LDL-C as a CVD risk factor, as well as effects of the LCD on other CVD risk factors. We have also reviewed findings that provide guidance as to whether statin therapy would be beneficial for individuals with high LDL-C on an LCD. Recent findings Multiple longitudinal trials have demonstrated the safety and effectiveness of the LCD, while also providing evidence of improvements in the most reliable CVD risk factors. Recent findings have also confirmed how ineffective LDL-C is in predicting CVD risk. Summary Extensive research has demonstrated the efficacy of the LCD to...
-
+26 +3
People Were Unwittingly Implanted With Fake Devices in Medical Scam, FBI Alleges
Stimwave allegedly told doctors that the plastic implantable rods would help ease patients' chronic pain.
Submit a link
Start a discussion